LUPINNSELupin Limited· PharmaceuticalsLowNeutral
Announced Tue, 28 Apr · 21:18 IST

Lupin Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Promoter Below 50pctOwnership Changes View source PDF

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹2303.00
prior close
₹2314.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.1+0.4+0.4+0.4+2.0+1.5+6.2+6.9-2.6-0.8-1.2+4.1
Up moveDown movePending
AI summary

Promoter Manju D. Gupta has submitted a declaration to NSE/BSE confirming that neither she nor the promoter group created any encumbrance (pledge) on Lupin Limited shares during Financial Year 2025-26. As of March 31, 2026, the promoter group holds 46.86% of paid-up equity capital, with Lupin Investments Private Limited being the largest holder at 45.32%. Individual family members hold minor stakes collectively adding up to about 1.54%. This is a routine compliance filing confirming no pledged shares among promoters.

Likely market impact

The absence of any pledge on promoter shares is a positive signal for shareholders, indicating promoters have not leveraged their holdings. However, the combined promoter holding at 46.86% remains below the 50% threshold, which may be relevant for takeover-related considerations.